![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-dexrazoxane | multiple interactions | ISO | RGD:1620826 | 6480464 | [Doxorubicin co-treated with Dexrazoxane] results in increased expression of DMAC2L mRNA | CTD | PMID:26873546 | (1->4)-beta-D-glucan | multiple interactions | ISO | RGD:1620826 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATP5S mRNA | CTD | PMID:36331819 | 1,2-dichloroethane | increases expression | ISO | RGD:1620826 | 6480464 | ethylene dichloride results in increased expression of ATP5S mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1620826 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of ATP5S mRNA | CTD | PMID:22206623 | 1,3-dinitrobenzene | decreases expression | EXP | | 6480464 | 3-dinitrobenzene results in decreased expression of DMAC2L mRNA | CTD | PMID:21983209 | 17beta-estradiol | multiple interactions | ISO | RGD:1343474 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of DMAC2L mRNA | CTD | PMID:17404688 | 17beta-estradiol | increases expression | ISO | RGD:1343474 | 6480464 | Estradiol results in increased expression of DMAC2L mRNA | CTD | PMID:21795739 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31826744 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | RGD:1620826 | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1620826 | 6480464 | Tetrachlorodibenzodioxin affects the expression of DMAC2L mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of DMAC2L mRNA | CTD | PMID:33387578 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 6-dinitrotoluene affects the expression of DMAC2L mRNA | CTD | PMID:21346803 | 2-methylcholine | affects expression | ISO | RGD:1343474 | 6480464 | beta-methylcholine affects the expression of DMAC2L mRNA | CTD | PMID:21179406 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:1620826 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of DMAC2L mRNA | CTD | PMID:26251327 | 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of DMAC2L mRNA | CTD | PMID:19483382 | 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of DMAC2L mRNA | CTD | PMID:19483382 | aconitine | decreases expression | EXP | | 6480464 | Aconitine results in decreased expression of DMAC2L protein | CTD | PMID:33236894 | all-trans-retinoic acid | decreases expression | ISO | RGD:1343474 | 6480464 | Tretinoin results in decreased expression of ATP5S mRNA | CTD | PMID:33167477 | amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of DMAC2L mRNA | CTD | PMID:19483382 | aristolochic acid A | decreases expression | ISO | RGD:1343474 | 6480464 | aristolochic acid I results in decreased expression of ATP5S mRNA | CTD | PMID:33212167 | benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of DMAC2L mRNA | CTD | PMID:19483382 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of DMAC2L mRNA | CTD | PMID:30816183 more ... | carbon nanotube | increases expression | ISO | RGD:1620826 | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of DMAC2L mRNA | CTD | PMID:19483382 | cobalt dichloride | decreases expression | ISO | RGD:1343474 | 6480464 | cobaltous chloride results in decreased expression of DMAC2L mRNA | CTD | PMID:19376846 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of DMAC2L mRNA | CTD | PMID:24386269 | copper atom | multiple interactions | ISO | RGD:1343474 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of DMAC2L mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:1343474 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of DMAC2L mRNA | CTD | PMID:20971185 | coumestrol | decreases expression | ISO | RGD:1343474 | 6480464 | Coumestrol results in decreased expression of DMAC2L mRNA | CTD | PMID:19167446 | dicrotophos | decreases expression | ISO | RGD:1343474 | 6480464 | dicrotophos results in decreased expression of DMAC2L mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | RGD:1343474 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of DMAC2L mRNA | CTD | PMID:19915844 | doxorubicin | multiple interactions | ISO | RGD:1620826 | 6480464 | [Doxorubicin co-treated with Dexrazoxane] results in increased expression of DMAC2L mRNA | CTD | PMID:26873546 | doxorubicin | decreases expression | ISO | RGD:1620826 | 6480464 | Doxorubicin results in decreased expression of DMAC2L mRNA | CTD | PMID:26873546 | doxorubicin | decreases expression | ISO | RGD:1343474 | 6480464 | Doxorubicin results in decreased expression of DMAC2L mRNA | CTD | PMID:29803840 | entinostat | multiple interactions | ISO | RGD:1343474 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMAC2L mRNA | CTD | PMID:27188386 | entinostat | decreases expression | ISO | RGD:1343474 | 6480464 | entinostat results in decreased expression of DMAC2L mRNA | CTD | PMID:26272509 | ethanol | affects expression | ISO | RGD:1620826 | 6480464 | Ethanol affects the expression of ATP5S mRNA | CTD | PMID:30319688 | fenvalerate | decreases expression | EXP | | 6480464 | fenvalerate results in decreased expression of DMAC2L protein | CTD | PMID:33656234 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of DMAC2L mRNA | CTD | PMID:24136188 | fluoranthene | multiple interactions | ISO | RGD:1620826 | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DMAC2L mRNA | CTD | PMID:28329830 | flutamide | increases expression | ISO | RGD:1620826 | 6480464 | Flutamide analog results in increased expression of DMAC2L mRNA, Flutamide results in increased expression of DMAC2L mRNA | CTD | PMID:17702527 | formaldehyde | decreases expression | ISO | RGD:1343474 | 6480464 | Formaldehyde results in decreased expression of DMAC2L mRNA | CTD | PMID:23649840 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of DMAC2L mRNA | CTD | PMID:22061828 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of DMAC2L mRNA | CTD | PMID:33387578 | glycidyl methacrylate | decreases expression | ISO | RGD:1343474 | 6480464 | glycidyl methacrylate results in decreased expression of DMAC2L protein | CTD | PMID:36641056 | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of DMAC2L mRNA | CTD | PMID:21396975 | irinotecan | decreases expression | ISO | RGD:1343474 | 6480464 | Irinotecan analog results in decreased expression of DMAC2L mRNA | CTD | PMID:18927307 | isoprenaline | multiple interactions | EXP | | 6480464 | [Isoproterenol co-treated with POSTN protein] results in decreased expression of DMAC2L mRNA | CTD | PMID:30303030 | L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of DMAC2L mRNA | CTD | PMID:19483382 | lipopolysaccharide | multiple interactions | ISO | RGD:1343474 | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5S mRNA | CTD | PMID:31059760 | methylmercury chloride | decreases expression | ISO | RGD:1343474 | 6480464 | methylmercuric chloride results in decreased expression of DMAC2L mRNA | CTD | PMID:28001369 | niclosamide | decreases expression | ISO | RGD:1343474 | 6480464 | Niclosamide results in decreased expression of DMAC2L mRNA | CTD | PMID:22576131 | omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of DMAC2L mRNA | CTD | PMID:19483382 | paracetamol | increases expression | ISO | RGD:1343474 | 6480464 | Acetaminophen results in increased expression of DMAC2L mRNA | CTD | PMID:22230336, PMID:25704631 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of DMAC2L mRNA | CTD | PMID:33387578 | paracetamol | affects expression | ISO | RGD:1620826 | 6480464 | Acetaminophen affects the expression of DMAC2L mRNA | CTD | PMID:17562736 | paracetamol | multiple interactions | ISO | RGD:1343474 | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5S mRNA | CTD | PMID:31059760 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1620826 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATP5S mRNA | CTD | PMID:36331819 | perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:1343474 | 6480464 | perfluorooctane sulfonic acid results in increased expression of ATP5S mRNA | CTD | PMID:25812627 | perfluorooctanoic acid | increases expression | ISO | RGD:1343474 | 6480464 | perfluorooctanoic acid results in increased expression of ATP5S mRNA | CTD | PMID:25812627 | phenobarbital | affects expression | ISO | RGD:1620826 | 6480464 | Phenobarbital affects the expression of DMAC2L mRNA | CTD | PMID:19136022 | pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of DMAC2L mRNA | CTD | PMID:19483382 | pirinixic acid | increases expression | ISO | RGD:1620826 | 6480464 | pirinixic acid results in increased expression of DMAC2L mRNA | CTD | PMID:20813756, PMID:23811191 | pirinixic acid | affects expression | ISO | RGD:1620826 | 6480464 | pirinixic acid affects the expression of DMAC2L mRNA | CTD | PMID:19136022 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of DMAC2L mRNA | CTD | PMID:19162173 | progesterone | multiple interactions | ISO | RGD:1343474 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of DMAC2L mRNA | CTD | PMID:17404688 | rotenone | increases expression | ISO | RGD:1620826 | 6480464 | Rotenone results in increased expression of DMAC2L mRNA | CTD | PMID:17702527 | SB 431542 | multiple interactions | ISO | RGD:1343474 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sulforaphane | decreases expression | ISO | RGD:1343474 | 6480464 | sulforaphane results in decreased expression of DMAC2L mRNA | CTD | PMID:31838189 | sunitinib | increases expression | ISO | RGD:1343474 | 6480464 | Sunitinib results in increased expression of DMAC2L mRNA | CTD | PMID:31533062 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of DMAC2L mRNA | CTD | PMID:31150632 | thapsigargin | decreases expression | ISO | RGD:1343474 | 6480464 | Thapsigargin results in decreased expression of DMAC2L mRNA | CTD | PMID:22378314 | theophylline | decreases expression | ISO | RGD:1343474 | 6480464 | Theophylline results in decreased expression of DMAC2L mRNA | CTD | PMID:18951874 | thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of DMAC2L mRNA | CTD | PMID:19483382 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of DMAC2L mRNA | CTD | PMID:23411599 | titanium dioxide | decreases expression | ISO | RGD:1620826 | 6480464 | titanium dioxide results in decreased expression of ATP5S mRNA | CTD | PMID:29264374 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of DMAC2L mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | ISO | RGD:1343474 | 6480464 | trichostatin A results in decreased expression of DMAC2L mRNA | CTD | PMID:24935251 | tunicamycin | decreases expression | ISO | RGD:1343474 | 6480464 | Tunicamycin results in decreased expression of DMAC2L mRNA | CTD | PMID:22378314 | valproic acid | decreases expression | ISO | RGD:1343474 | 6480464 | Valproic Acid results in decreased expression of DMAC2L mRNA, Valproic Acid results in decreased expression of DMAC2L protein | CTD | PMID:24383497 more ... | valproic acid | multiple interactions | ISO | RGD:1343474 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMAC2L mRNA | CTD | PMID:27188386 | vorinostat | decreases expression | ISO | RGD:1343474 | 6480464 | vorinostat results in decreased expression of DMAC2L mRNA | CTD | PMID:27188386 | |